Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

    The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.

    OverviewSimilar Grants
    OverviewSimilar Grants

    NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

    This grant supports early stage investigators proposing innovative, high-risk research on the biological and behavioral mechanisms underlying substance use disorders.

    HHS-NIH11Forecasted May 26, 2027$375,000Forecasted

    Drug Development Infrastructure Supporting the Research Community in Medication Repurposing for Substance Use Disorders

    NIDA seeks to support shared drug-development infrastructure to help academic and biotech researchers repurpose medications for substance use disorders and advance them toward clinical development.

    HHS-NIH11Forecasted Jun 1, 2027Newly ListedForecasted

    Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

    Supports collaborative research to map neural ensembles responding to addictive substances and build a multimodal database linking their activity to substance use behaviors; clinical trials are not allowed.

    HHS-NIH11Due Feb 8, 2027$3,500,000

    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

    NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.

    HHS-NIH11Due Feb 19, 2027

    Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

    This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.

    HHS-NIH11Forecasted Jun 8, 2027$1,000,000Forecasted